| 1Chlordiazepoxide |
|---|
| 2Flurazepam |
| 3Oxazepam |
| 4Clonazepam |
| 5Temazepam |
| 6Diazepam |
Compound Name Chlordiazepoxide |
CID 2712 |
Molecular Formula C16H14ClN3O |
Molecular Weight 299 |
No. Hydrogen Bond Acceptors 4 |
No. Hydrogen Bond Donors 1 |
Applications
Benzodiazepines on Synergi 2.5µm Max-RP 20 x 2.0mm Mini-Column
15463
Separation Mode: Reversed Phase
Reversed Phase
Max-RP
HPLC
Antiemetics
Clinical
Forensics/Toxicology
Pharmaceutical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 15463)
Column: | ||||||||||||||||||||
Brand Name: | ||||||||||||||||||||
Part No: | ||||||||||||||||||||
Phase Name: Max-RP | ||||||||||||||||||||
Elution Type: Gradient | ||||||||||||||||||||
Mobile Phase: A: 0.1% Formic acid in Water B: 0.1% Formic acid in Acetonitrile | ||||||||||||||||||||
Gradient Profile:
| ||||||||||||||||||||
Flow Rate: 0.6 mL/min | ||||||||||||||||||||
Temperature: 0°C | ||||||||||||||||||||
Detection: UV-Vis Abs.-Variable Wave.(UV) @ 254 nm (22°C) |
Order Items Used in This Application
00M-4372-B0-CE
Synergi 2.5 µm Max-RP 100 Å, LC Column 20 x 2 mm, MercuryMS, Ea
Qty:
Similar Applications
search
Chlordiazepoxide
Gemini 5 µm C18 110 Å, LC Column 150 x 3 mm, Ea
Reversed Phase
Luna 3 µm C18(2) 100 Å, LC Column 20 x 2 mm, MercuryMS, Ea
Reversed Phase
Gemini 5 µm C18 110 Å, LC Column 150 x 3 mm, Ea
Reversed Phase
Luna 3 µm C18(2) 100 Å, LC Column 20 x 2 mm, MercuryMS, Ea
Reversed Phase
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
